Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach

Uttamrao, P.P. and Sathyaseelan, C. and Patro, L.P.P. and Rathinavelan, T. (2021) Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach. Frontiers in Immunology, 12. ISSN 25740962

Full text not available from this repository. (Request a copy)

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kills thousands of people worldwide every day, thus necessitating rapid development of countermeasures. Immunoinformatics analyses carried out here in search of immunodominant regions in recently identified SARS-CoV-2 unannotated open reading frames (uORFs) have identified eight linear B-cell, one conformational B-cell, 10 CD4+ T-cell, and 12 CD8+ T-cell promising epitopes. Among them, ORF9b B-cell and T-cell epitopes are the most promising followed by M.ext and ORF3c epitopes. ORF9b40-48 (CD8+ T-cell epitope) is found to be highly immunogenic and antigenic with the highest allele coverage. Furthermore, it has overlap with four potent CD4+ T-cell epitopes. Structure-based B-cell epitope prediction has identified ORF9b61-68 to be immunodominant, which partially overlaps with one of the linear B-cell epitopes (ORF9b65-69). ORF3c CD4+ T-cell epitopes (ORF3c2-16, ORF3c3-17, and ORF3c4-18) and linear B-cell epitope (ORF3c14-22) have also been identified as the candidate epitopes. Similarly, M.ext and 7a.iORF1 (overlap with M and ORF7a) proteins have promising immunogenic regions. By considering the level of antigen expression, four ORF9b and five M.ext epitopes are finally shortlisted as potent epitopes. Mutation analysis has further revealed that the shortlisted potent uORF epitopes are resistant to recurrent mutations. Additionally, four N-protein (expressed by canonical ORF) epitopes are found to be potent. Thus, SARS-CoV-2 uORF B-cell and T-cell epitopes identified here along with canonical ORF epitopes may aid in the design of a promising epitope-based polyvalent vaccine (when connected through appropriate linkers) against SARS-CoV-2. Such a vaccine can act as a bulwark against SARS-CoV-2, especially in the scenario of emergence of variants with recurring mutations in the spike protein. © Copyright © 2021 Uttamrao, Sathyaseelan, Patro and Rathinavelan.

[error in script]
IITH Creators:
IITH CreatorsORCiD
Rathinavelan, Thenmalarchelvihttp://orcid.org/0000-0002-1142-0583
Item Type: Article
Uncontrolled Keywords: B-cell epitopes, Canonical protein epitopes, epitope-based polyvalent vaccine, HLA I supergroups, ORF9b, SARS-CoV-2, T-cell epitopes, uORFs
Subjects: Others > Biotechnology
Divisions: Department of Biotechnology
Depositing User: Mrs Haseena VKKM
Date Deposited: 18 Apr 2022 11:20
Last Modified: 18 Apr 2022 11:20
URI: http://raiith.iith.ac.in/id/eprint/9212
Publisher URL: https://pubs.acs.org/doi/10.1021/acsaem.1c01522
OA policy: https://v2.sherpa.ac.uk/id/publication/37813
Related URLs:

Actions (login required)

View Item View Item
Statistics for RAIITH ePrint 9212 Statistics for this ePrint Item